NetworkNewsBreaks – Rockwell Medical, Inc. (NASDAQ: RMTI) Appoints New President, CEO to Lead Next Phase of Growth
Rockwell Medical (NASDAQ: RMTI), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced that its Board of Directors has appointed Russell H. Ellison, M.D., M.Sc. as president and chief executive officer, effective immediately. According to the update, Dr. Ellison will continue to serve as a member of Rockwell Medical’s Board, and Stuart Paul has resigned as president and chief executive officer and as a member of the Company’s Board of Directors. “Rockwell Medical is focused on transforming the treatment of iron deficiency and anemia around the world to improve outcomes for…







